Characteristics and Outcomes of Patients with CLL and CDKN2A/B Deletion by Fluorescence in situ Hybridization.
Samantha M TeierleYing HuangAdam S KittaiSeema A BhatMichael Rhodes GreverKerry A RogersWeiqiang ZhaoDaniel JonesJohn C ByrdMatthew R AvenariusNyla A HeeremaJennifer A WoyachCecelia R MillerPublished in: Blood advances (2023)